Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development for Outbreak Originating in China
Thursday, January 23, 2020 - 15:00
in Biology & Nature
Wistar announces today that they are part of a team to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has infected hundreds in China and other countries, including the U.S., and resulted in numerous deaths to date. Wistar is part of a collaboration funded by the Coalition for Epidemic Preparedness Innovations (CEPI).